Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
Common cold coronaviruses hinder antibody immune response to SARS-CoV-2 infection
St. Jude study also suggests that prior immunity to common cold coronaviruses does not protect against SARS-CoV-2 infection.
-
Modular super-enhancer controls retinal development
Scientists at St. Jude identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a ‘modular’ super-enhancer.
-
Understanding how autoactivation triggers cell death
Scientists from St. Jude have captured the structure of autoactivated BAK, a key protein for triggering apoptosis in cancer cells.
-
Secrets of regulatory T cell development reveal clinical possibilities
St. Jude scientists have identified key steps in production of the regulatory T cells that have a role in everything from autoimmune disorders to cancer.
-
SARS-CoV-2 vaccination creates a strong, persistent T-cell response
St. Jude Immunology study details how T cells respond to mRNA vaccination for SARS-CoV-2. Published in Cell, in collaboration with Washington University St. Louis.
-
Research reveals features that influence phase separation
St. Jude researchers reveal more details of processes cells use to organize the proteins within them, which may provide insight into neurological diseases and cancer.